NCT00890474

Moxibustion for Fetus in Breech Presentation

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 212 (actual)
• Sponsor: University Hospital, Geneva · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

Objective: To evaluate moxibustion of the BL67 acupoint between 34 and 38 weeks of gestation to facilitate cephalic version of breech presentation in a Western setting. The hypothesis is that moxibustion increase the likelihood of cephalic version. Design: Randomised controlled trial Setting: University hospital. Population: A total of 212 consenting women between 34 and 36 weeks of gestation with a single fetus in breech presentation will be randomised to moxibustion (n=106) or expectant management (n=106). Main Outcome Measure: Cephalic presentation at delivery or before external cephalic version.

Conditions

• Breech Presentation

Interventions

Type	Name	Description
PROCEDURE	Moxibustion of the BL67 acupoint	Moxibustion sessions every day (every other day in hospital, self-administration at home the other day) during a maximum of 14 days. Stopped if cephalic version.

Timeline

• Start date: 2004-10-01
• Primary completion: 2008-12-01
• Completion: 2009-01-01
• First posted: 2009-04-29
• Last updated: 2009-04-29

Locations

1 site across 1 country: Switzerland